BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kabakov AE, Yakimova AO. Hypoxia-Induced Cancer Cell Responses Driving Radioresistance of Hypoxic Tumors: Approaches to Targeting and Radiosensitizing. Cancers (Basel) 2021;13:1102. [PMID: 33806538 DOI: 10.3390/cancers13051102] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Kabakov AE, Gabai VL. HSP70s in Breast Cancer: Promoters of Tumorigenesis and Potential Targets/Tools for Therapy. Cells 2021;10:3446. [PMID: 34943954 DOI: 10.3390/cells10123446] [Reference Citation Analysis]
2 Son SW, Yun BD, Song MG, Lee JK, Choi SY, Kuh HJ, Park JK. The Hypoxia-Long Noncoding RNA Interaction in Solid Cancers. Int J Mol Sci 2021;22:7261. [PMID: 34298879 DOI: 10.3390/ijms22147261] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Jokar S, Marques IA, Khazaei S, Martins-marques T, Girao H, Laranjo M, Botelho MF. The Footprint of Exosomes in the Radiation-Induced Bystander Effects. Bioengineering 2022;9:243. [DOI: 10.3390/bioengineering9060243] [Reference Citation Analysis]
4 Ouellette MM, Zhou S, Yan Y. Cell Signaling Pathways That Promote Radioresistance of Cancer Cells. Diagnostics (Basel) 2022;12:656. [PMID: 35328212 DOI: 10.3390/diagnostics12030656] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Birindelli G, Drobnjakovic M, Morath V, Steiger K, D'Alessandria C, Gourni E, Afshar-Oromieh A, Weber W, Rominger A, Eiber M, Shi K. Is Hypoxia a Factor Influencing PSMA-Directed Radioligand Therapy?-An In Silico Study on the Role of Chronic Hypoxia in Prostate Cancer. Cancers (Basel) 2021;13:3429. [PMID: 34298642 DOI: 10.3390/cancers13143429] [Reference Citation Analysis]
6 Deng X, Song Q, Zhang Y, Liu W, Hu H, Zhang Y. Tumour microenvironment-responsive nanoplatform based on biodegradable liposome-coated hollow MnO2 for synergistically enhanced chemotherapy and photodynamic therapy. J Drug Target 2021;:1-14. [PMID: 34709119 DOI: 10.1080/1061186X.2021.1999961] [Reference Citation Analysis]
7 Alamilla-Presuel JC, Burgos-Molina AM, González-Vidal A, Sendra-Portero F, Ruiz-Gómez MJ. Factors and molecular mechanisms of radiation resistance in cancer cells. Int J Radiat Biol 2022;:1-45. [PMID: 35225732 DOI: 10.1080/09553002.2022.2047825] [Reference Citation Analysis]
8 Poon DJJ, Tay LM, Ho D, Chua MLK, Chow EK, Yeo ELL. Improving the therapeutic ratio of radiotherapy against radioresistant cancers: Leveraging on novel artificial intelligence-based approaches for drug combination discovery. Cancer Lett 2021;511:56-67. [PMID: 33933554 DOI: 10.1016/j.canlet.2021.04.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Ancel J, Perotin JM, Dewolf M, Launois C, Mulette P, Nawrocki-Raby B, Dalstein V, Gilles C, Deslée G, Polette M, Dormoy V. Hypoxia in Lung Cancer Management: A Translational Approach. Cancers (Basel) 2021;13:3421. [PMID: 34298636 DOI: 10.3390/cancers13143421] [Reference Citation Analysis]
10 Dewhirst MW, Oleson JR, Kirkpatrick J, Secomb TW. Accurate Three-Dimensional Thermal Dosimetry and Assessment of Physiologic Response Are Essential for Optimizing Thermoradiotherapy. Cancers 2022;14:1701. [DOI: 10.3390/cancers14071701] [Reference Citation Analysis]
11 Li L, Yu J, Cheng S, Peng Z, Ben-David Y, Luo H. Transcription factor Fli-1 as a new target for antitumor drug development. Int J Biol Macromol 2022;209:1155-68. [PMID: 35447268 DOI: 10.1016/j.ijbiomac.2022.04.076] [Reference Citation Analysis]
12 Rakotomalala A, Escande A, Furlan A, Meignan S, Lartigau E. Hypoxia in Solid Tumors: How Low Oxygenation Impacts the "Six Rs" of Radiotherapy. Front Endocrinol (Lausanne) 2021;12:742215. [PMID: 34539584 DOI: 10.3389/fendo.2021.742215] [Reference Citation Analysis]